How many clinical trials are studying [177Lu]Lu-PSMA I&T?

3 recruiting trials in our tracked data involve [177Lu]Lu-PSMA I&T.

What conditions is [177Lu]Lu-PSMA I&T being studied for?

In our tracked recruiting trials, [177Lu]Lu-PSMA I&T is being studied in trials for Prostate Cancer, Prostate Cancer Recurrent.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase 2 3

Condition	Trials
Prostate Cancer · [177Lu]Lu-PSMA I&T for Prostate Cancer	3
Prostate Cancer Recurrent	1

Lu-PSMA and Stereotactic Radiotherapy Versus Radiotherapy Alone for Prostate Cancer (LUST)
NCT05893381 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 2 locations
Neoadjuvant PSMA-RLT in Oligometastatic PCa
NCT06259123 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Male · 1 location
PSMA-RLT in Biochemically Recurrent PCa
NCT06220188 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: Male · 1 location

3 recruiting trials across 2 conditions.

No. For the full record, search ClinicalTrials.gov.